Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy
Nitric oxide (NO) is a key molecule in cardiovascular homeostasis and its abnormal delivery is highly associated with the occurrence and development of cardiovascular disease (CVD). The assessment and manipulation of NO delivery is crucial to the diagnosis and therapy of CVD, such as endothelial dys...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d2c6afe4f2734a579c3cb8c8696edcc0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d2c6afe4f2734a579c3cb8c8696edcc0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d2c6afe4f2734a579c3cb8c8696edcc02021-11-25T17:53:59ZDelivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy10.3390/ijms2222121661422-00671661-6596https://doaj.org/article/d2c6afe4f2734a579c3cb8c8696edcc02021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12166https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Nitric oxide (NO) is a key molecule in cardiovascular homeostasis and its abnormal delivery is highly associated with the occurrence and development of cardiovascular disease (CVD). The assessment and manipulation of NO delivery is crucial to the diagnosis and therapy of CVD, such as endothelial dysfunction, atherosclerotic progression, pulmonary hypertension, and cardiovascular manifestations of coronavirus (COVID-19). However, due to the low concentration and fast reaction characteristics of NO in the cardiovascular system, clinical applications centered on NO delivery are challenging. In this tutorial review, we first summarized the methods to estimate the in vivo NO delivery process, based on computational modeling and flow-mediated dilation, to assess endothelial function and vulnerability of atherosclerotic plaque. Then, emerging bioimaging technologies that have the potential to experimentally measure arterial NO concentration were discussed, including Raman spectroscopy and electrochemical sensors. In addition to diagnostic methods, therapies aimed at controlling NO delivery to regulate CVD were reviewed, including the NO release platform to treat endothelial dysfunction and atherosclerosis and inhaled NO therapy to treat pulmonary hypertension and COVID-19. Two potential methods to improve the effectiveness of existing NO therapy were also discussed, including the combination of NO release platform and computational modeling, and stem cell therapy, which currently remains at the laboratory stage but has clinical potential for the treatment of CVD.Tianxiang MaZhexi ZhangYu ChenHaoran SuXiaoyan DengXiao LiuYubo FanMDPI AGarticlenitric oxide deliverycomputational modelingflow-mediated dilationNO release platforminhaled NO therapystem cell therapyBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12166, p 12166 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
nitric oxide delivery computational modeling flow-mediated dilation NO release platform inhaled NO therapy stem cell therapy Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
nitric oxide delivery computational modeling flow-mediated dilation NO release platform inhaled NO therapy stem cell therapy Biology (General) QH301-705.5 Chemistry QD1-999 Tianxiang Ma Zhexi Zhang Yu Chen Haoran Su Xiaoyan Deng Xiao Liu Yubo Fan Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy |
description |
Nitric oxide (NO) is a key molecule in cardiovascular homeostasis and its abnormal delivery is highly associated with the occurrence and development of cardiovascular disease (CVD). The assessment and manipulation of NO delivery is crucial to the diagnosis and therapy of CVD, such as endothelial dysfunction, atherosclerotic progression, pulmonary hypertension, and cardiovascular manifestations of coronavirus (COVID-19). However, due to the low concentration and fast reaction characteristics of NO in the cardiovascular system, clinical applications centered on NO delivery are challenging. In this tutorial review, we first summarized the methods to estimate the in vivo NO delivery process, based on computational modeling and flow-mediated dilation, to assess endothelial function and vulnerability of atherosclerotic plaque. Then, emerging bioimaging technologies that have the potential to experimentally measure arterial NO concentration were discussed, including Raman spectroscopy and electrochemical sensors. In addition to diagnostic methods, therapies aimed at controlling NO delivery to regulate CVD were reviewed, including the NO release platform to treat endothelial dysfunction and atherosclerosis and inhaled NO therapy to treat pulmonary hypertension and COVID-19. Two potential methods to improve the effectiveness of existing NO therapy were also discussed, including the combination of NO release platform and computational modeling, and stem cell therapy, which currently remains at the laboratory stage but has clinical potential for the treatment of CVD. |
format |
article |
author |
Tianxiang Ma Zhexi Zhang Yu Chen Haoran Su Xiaoyan Deng Xiao Liu Yubo Fan |
author_facet |
Tianxiang Ma Zhexi Zhang Yu Chen Haoran Su Xiaoyan Deng Xiao Liu Yubo Fan |
author_sort |
Tianxiang Ma |
title |
Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy |
title_short |
Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy |
title_full |
Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy |
title_fullStr |
Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy |
title_full_unstemmed |
Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy |
title_sort |
delivery of nitric oxide in the cardiovascular system: implications for clinical diagnosis and therapy |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/d2c6afe4f2734a579c3cb8c8696edcc0 |
work_keys_str_mv |
AT tianxiangma deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy AT zhexizhang deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy AT yuchen deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy AT haoransu deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy AT xiaoyandeng deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy AT xiaoliu deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy AT yubofan deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy |
_version_ |
1718411889465098240 |